Carmen Härdtner
University of Freiburg(DE)Universitäts-Herzzentrum Freiburg-Bad Krozingen(DE)
Publications by Year
Research Areas
Atherosclerosis and Cardiovascular Diseases, Adipokines, Inflammation, and Metabolic Diseases, Lipoproteins and Cardiovascular Health, Cell Adhesion Molecules Research, Pancreatic function and diabetes
Most-Cited Works
- → Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation(2019)165 cited
- → P2X 7 Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice(2017)100 cited
- → Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice(2019)81 cited
- → Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering(2020)76 cited
- → Purinergic receptor Y2 (P2Y2)- dependent VCAM-1 expression promotes immune cell infiltration in metabolic syndrome(2018)47 cited
- → Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression(2016)39 cited
- → High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells(2013)39 cited
- → Diabetes changes gene expression but not DNA methylation in cardiac cells(2020)34 cited
- → Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe mice(2021)29 cited
- → (−)-Epigallocatechin-3-gallate, a green tea-derived catechin, synergizes with celecoxib to inhibit IL-1-induced tumorigenic mediators by human pancreatic adenocarcinoma cells Colo357(2012)28 cited